RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK)
Germany · Delayed Price · Currency is EUR 13.20
0.00 (0.00%)
At close: Jan 23, 2026
RHÖN-KLINIKUM Aktiengesellschaft Employees
RHÖN-KLINIKUM Aktiengesellschaft had 14,067 employees as of December 31, 2024. The number of employees decreased by 4,179 or -22.90% compared to the previous year.
Employees
14,067
Change (1Y)
-4,179
Growth (1Y)
-22.90%
Revenue / Employee
€102,567
Profits / Employee
€2,001
Market Cap
883.59M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 14,067 | -4,179 | -22.90% | 14,067 | 0 |
| Dec 31, 2023 | 18,246 | 106 | 0.58% | 10,017 | 8,229 |
| Dec 31, 2022 | 18,140 | -87 | -0.48% | 10,249 | 7,891 |
| Dec 31, 2021 | 18,227 | -222 | -1.20% | 10,143 | 8,084 |
| Dec 31, 2020 | 18,449 | 307 | 1.69% | 10,523 | 7,926 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 59,020 |
| Gerresheimer AG | 12,142 |
| Evotec SE | 4,740 |
| Dermapharm Holding SE | 3,610 |
| Redcare Pharmacy NV | 1,827 |
RHÖN-KLINIKUM Aktiengesellschaft News
- 11 days ago - RHÖN-KLINIKUM Adjusts 2025 EBITDA Forecast: What Investors Need to Know - Wallstreet:Online
- 11 days ago - EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft adjusts the EBITDA forecast for financial year 2025 - Wallstreet:Online
- 2 months ago - Rhoen-Klinikum's Q3 2025: Solid Results Drive Growth - Wallstreet:Online
- 6 months ago - Rhoen-Klinikum Shines in H1 2025 with Strong Performance - Wallstreet:Online
- 9 months ago - Rhoen-Klinikum Steady in Q1 2025, Confirms Positive Outlook - Wallstreet:Online
- 10 months ago - Rhoen-Klinikum's Prof. Kaltenbach Exits After Stellar Year - Wallstreet:Online
- 10 months ago - EQS-News: RHÖN-KLINIKUM AG once again reports a successful financial year – CEO Prof. Kaltenbach leaves the Board of Management as planned - Wallstreet:Online
- 1 year ago - Rhoen-Klinikum Shines: Strong 9-Month Performance, Outlook Confirmed - Wallstreet:Online